Skip to content
★ Sign in to follow
RUA Life Sciences plc logo

RUA Life Sciences plc Stock: price and insider trades · United Kingdom

ISIN GB0033360586GB·Mcap £17.7M

No insider purchase over the last 90 days. The latest, by Lachlan Smith, was filed 06 May 2025.

RUA Life Sciences plc: what insiders have been doing

Every trade that managers of RUA Life Sciences plc disclose to RNS (LSE) is tracked on this page. The past year has been quiet: not a single insider filing for RUA Life Sciences plc. The previous disclosure was published on 6 May 2025.

Over the whole record (from 2025), the tally stands at 2 purchases and no sales.

This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Insider Decl.
2
Thresholds
n/a
Buy Volume
€13,187
2 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Bill Brown1 buy
Lachlan Smith1 buy

Since the insiders bought

  • Filed 06 May 2025 · 551 days ago · €2,821
    +100.0%
    Entry £0.12 · Close at T+365 £0.24
  • Filed 04 Feb 2025 · 642 days ago · €10k
    +7.4%
    Entry £0.14 · Close at T+365 £0.15

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 20,799 of 26,897 companies
32.8
score / 100
Value
19
Quality
47
FCF yld-8.0%
Earn yld-8.3%
EV/EBITDA·
ROE·
Gross mgn81%
Net mgn-66%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2024

FY ended March 2024 · cache

£0.29
Analyst consensus
1 analysts
·
£0.50Target £0.50(+75%)£0.50
Income statement
Revenue£2.2M
Gross profit£1.8M81% margin
EBITDA-£1.6M-73% margin
Net income-£1.4M6.1% margin
Valuation
P/Book252.2x
Beta0.99
Balance sheet & cash
Market cap£17.7M
Total debt£389k
Free Cash Flow-£1.4M
Debt / Equity9%
Profitability & ownership
% insiders19.2%
% institutions17.6%
Last declaration on 6 May 2025
Declarations2 total
  • ▲
    Chief Financial OfficerExecutives
    2,399 GBP27RNS
    20,228 shares@ £0.1186100.0% of flowLondon Stock Exchange, AIMISIN GB0033360586RNS:5642317
    Canonical exit: 31 Jul 2025 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    8,645 GBP30RNS
    0100.0% of flowLondon Stock Exchange, AIMISIN GB0033360586RNS:5524855
    Canonical exit: 4 May 2025 (T+90)

2 of 2 declarations

About RUA Life Sciences plc

RUA Life Sciences plc is a company focused on developing innovative medical solutions. It specializes in the manufacturing of medical devices and health technologies.